Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × Dexamethasone × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 56 Recurrence 8 Burkitt Lymphoma 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Immunoglobulin Light-chain Amyloidosis 7 Neoplasms 5 Leukemia, Biphenotypic, Acute 4 Prostatic Neoplasms 3 Paraproteinemias 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Neoplasms, Plasma Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Adenocarcinoma 2 beta-Thalassemia 1 Vomiting 1 Triple Negative Breast Neoplasms 1 Thalassemia 1 Supratentorial Neoplasms 1 Smoldering Multiple Myeloma 1 Renal Insufficiency 1 Radiation Pneumonitis 1 Radiation Injuries 1 Prostatic Neoplasms, Castration-Resistant 1

Interventions

Dasatinib 2 ponatinib 1 pembrolizumab 1 nilotinib 1 decitabine and cedazuridine drug combination 1 Practice Management, Medical 1 Interviews as Topic 1 Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡